Dominik Schumacher
Chief Executive Officer Tubulis
Dominik Schumacher, PhD, serves as the Chief Executive Officer of Tubulis.
From the early founding phase on, Dominik successfully secured several prestigious start-up awards for Tubulis. In 2019, he was awarded as one of MIT’s Innovators Under 35. Dominik is also a Life Science Investor and has been actively investing in young, European biotech companies. Prior to co-founding Tubulis in 2018, Dominik worked at the Leibniz-Forschungsinstitut für Molekulare Pharmacology (FMP) and as a group leader at the Ludwig Maximillian University (LMU) in Munich.
Dominik obtained his PhD from the Humboldt University of Berlin, Germany and studied Chemistry and Economics at the Heinrich Heine University in Düsseldorf.
Seminars
Wednesday 14th October 2026
Highlighting the Clinical Promise from Phase I/IIa Development of TUB-040 in Platinum Resistant Ovarian Cancer
5:00 pm
- Explaining TUB-040 ADC design innovation across payload, conjugation and validated NaPi2b target
- Detailing proof-of-concept data and strong ORR from the emerging clinical profile of TUB-040
- Contrasting clinical performance to preclinical data to assess how well TUB-040 innovation has been translated into patient studies
- Highlighting the clinical development strategy and potential therapeutic impact of TUB-040 in PROC with an existing approved ADC therapy
